Call for Abstract

8th International Conference on Blood and Oncology Research, will be organized around the theme “We share something that kills Cancer”

Oncology Research 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Oncology Research 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Oncology is a branch of medicine that deals with tumours. A medical expert who practices oncology is an oncologist. Oncologists may isolate on the origin of the sort of action provided to treat the cancer. A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy. A surgical oncologist eliminates the tumor and nearby tissue during an operation. A radiation oncologist treats cancer using radiation therapy. Gynaecologic oncology is efforts on different cancers of the female reproductive system. Molecular oncology is the study of chemistry of cancer and tumor cell at its molecular cell. Oncologists may divide on the basis of the type of treatment provided to treat the cancer.

  • Track 1-1Medical, Surgical & Clinical Oncology
  • Track 1-2Cellular & Molecular Oncology
  • Track 1-3Haematology Oncology
  • Track 1-4Radiation Oncology
  • Track 1-5Dental Oncology
  • Track 1-6Gynaecologic Oncology
  • Track 1-7Paediatric Oncology
  • Track 1-8Gastrointestinal Oncology

Cancer is the term given to a collection of related diseases. Numerous malignancies shape strong tumours, which are masses of tissue. Cancer of the blood, for example, leukaemia, for the most part don't shape strong tumor. Cancerous tumours are malignant, which means they can spread into, or invade, nearby tissues. There are various types of cancer most common type of cancer on the list is breast cancer.

  • Track 2-1Breast Cancer
  • Track 2-2Skin Cancer
  • Track 2-3Pancreatic Cancer
  • Track 2-4Gynaecologic Cancer
  • Track 2-5Kidney Cancer
  • Track 2-6Blood Cancer
  • Track 2-7Colorectal Cancer
  • Track 2-8Oral Cancer
  • Track 2-9Liver Cancer
  • Track 2-10Cervical Cancer
  • Track 2-11Lung Cancer
  • Track 2-12Throat Cancer

Cancer stem cells (CSCs) are malignancy cells found inside tumours or haematological diseases that have attributes related with typical undifferentiated organisms, particularly the capacity to offer ascent to all cell sorts found in a specific malignancy test.

Stem cell transplants are techniques that re-establish blood-framing undeveloped cells in individuals who have had theirs devastated by the high measurements of chemotherapy or radiation treatment that are utilized to treat certain tumours.

  • Track 3-1Stem Cell Research
  • Track 3-2Stem Cell Research in Cancer
  • Track 3-3CSCs and Cancer Treatment

Metastasis, or metastatic ailment, is the spread of a malignancy or other infection starting with one organ or part then onto the next not specifically associated with it. An oncovirus is an infection that can bring about tumor. This term started from investigations of intensely changing retroviruses, regularly called oncornaviruses to signify their RNA infection beginning. Physical and Chemical Agents are changes the genetic material like DNA of a living beings that can changes the elucidation and interpretation and DNA replication which can drives cell death.

Tumor Vaccines uses to treat the development the disease might exist malignancy or keeps the progression malignancy. Nourishment and disease great sustenance is imperative to the tumor patients its offers quality to the general population. Changes in Lifestyle are likewise aware to increments in the growth rates like smoking drinking no physical action.

  • Track 4-1Risk Factors for Cancer
  • Track 4-2Carcinogenesis
  • Track 4-3Metastatic Tumours
  • Track 4-4Oncovirus
  • Track 4-5Mutagenesis
  • Track 4-6Cancer Genetics and Genomics
  • Track 4-7Causes and Prevention Research
  • Track 4-8E-Cigarettes Research

Most tumours are at first perceived either in view of the presence of signs or manifestations or through screening. Neither of these prompts to a complete conclusion, which requires the examination of a tissue test by a pathologist. Individuals with suspected cancer are examined with medicinal tests. Diagnostic testing involves tests and procedures to confirm the presence of cancer and identify the correct tumor type, location, extent and stage. Cancer treatment use sophisticated diagnostic technology to pinpoint and evaluate tumours, and develop a personalized treatment plan.

  • Track 5-1Biopsy
  • Track 5-2Cancer Imaging Tests
  • Track 5-3Fact Sheets in Cancer Diagnosis
  • Track 5-4Complete Blood Count (CBC)
  • Track 5-5Molecular Diagnostics
  • Track 5-6Cancer Diagnostics Kits

A sort of treatment that utilizations drugs or different substances to recognize and assault particular sorts of cancer cells with less damage to typical cells. Some focused on treatments obstruct the activity of specific compounds, proteins, or different atoms required in the development and spread of growth cells. Different short of targeted therapies help the immune system kill cancer cells or deliver toxic materials directly to cancer cells and kill them. Targeted treatment may have less reactions than different sorts of malignancy treatment. Most focused on treatments are either little particle medications or monoclonal antibodies.

Therapeutics appropriately refers to the utilization of medications and the strategy for their organization in the treatment of cancer. Cancer therapeutics a joined train of medicinal oncology, which might be characterized as the non-surgical, non-radio therapeutic administration of patients with strong tumours and clinical pharmacology, in light of great cytotoxic chemotherapy and the new flag transduction inhibitors.

  • Track 6-1Surgery
  • Track 6-2Chemotherapy
  • Track 6-3Anti-Cancer Therapy
  • Track 6-4Radiotherapy
  • Track 6-5Immunotherapy
  • Track 6-6Oncolytic Virotherapy
  • Track 6-7Nuclear Medicine
  • Track 6-8Drug & Gene Therapy
  • Track 6-9Nanotechnology in Cancer Drugs

Individuals confronting growth are normally worried about what's on the future.  A prognosis gives a thought of the reasonable course and result of an infection that is, the shot that a patient will recover or have a recurrence. Prognosis can be articulated, (for example, excellent, good, poor) or numbers. It's frequently communicated as a five-or ten-year survival rate, which is a estimate of what number of individuals are probably going to be alive five or ten years after finding.

  • Track 7-1Origin and Etymology
  • Track 7-2Determining prognosis
  • Track 7-3Cancer Cure

Cancer Pharmacology is at the interface of portraying key procedures in growth science and comprehension the systems of activities of specialists that regulate expansion, survival, mutagenesis, and tumorgenesis. Different research methodologies are being utilized and run from present day strategies in cell and atomic science utilizing as a part of vitro model frameworks to in vivo models of carcinogenesis to front line scientific ways to deal with distinguish and measure DNA adducts and transformations. For the most part, a multiplying or more in plasma drug focus the potential for upgraded antagonistic or valuable medication reaction Drug cooperation in oncology are of specific significance attributable to the tight healing list and the immutable lethality of anticancer specialists.

  • Track 8-1Pharmacokinetics
  • Track 8-2Pharmacodynamics
  • Track 8-3Clinical Toxicology
  • Track 8-4Cancer and Drug Interactions
  • Track 8-5Anti-cancer Drugs and Delivery
  • Track 8-6Nanotechnology and Nanomedicine
  • Track 8-7Therapeutic Antibodies
  • Track 8-8Novel Drug Delivery System
  • Track 8-9Cancer Drug Designing

Toxicology and Cancer Biology the exploration is being done in ecotoxicology, hereditary toxicology and Cancer science. Inside the system of these fundamental fields we research the water biological communities and the pollution impacts, the harms of hereditary material and the origin and advancement of cancer diseases. The Toxicology and Cancer Biology Research Cluster effectively underpins parts of essential research into natural, human and animal medical problems as they identify with the orders of Toxicology and Cancer Biology.

A cancer biomarker can be a procedure substance that demonstrates the nearness of tumor in the body. It might be a particle discharged by tumor cells or a specific reaction of the body as a result of the nearness of growth. Biomarkers may hereditary, epigenetic, proteomic, glycomic, or imaging. They can be utilized for disease analysis, forecast, medication, the study of disease transmission of malignancy. Those biomarkers that are especially connected with transformations offer a quantitative approach to decide when people are inclined to specific sorts of diseases. In numerous ranges of pharmaceutical, biomarkers are restricted to proteins identifiable or quantifiable in the blood or urine. In any case, the term is frequently used to cover any atomic, biochemical, physiological, or anatomical property that can be evaluated or measured.

  • Track 10-1Biomarkers in Cancer Research
  • Track 10-2Biomarkers in Medicine
  • Track 10-3Biomarkers in Cancer Medicine
  • Track 10-4Risk Assessment, Diagnosis
  • Track 10-5Molecular Cancer Biomarkers
  • Track 10-6Cancer Metabolomics and Biomarkers
  • Track 10-7Prognostic Biomarkers

Hematology involves with the study, diagnosis, treatment, and prevention of diseases related to the blood. The study is based on treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.

 
  • Track 11-1Haematology and Lymph
  • Track 11-2Blood Components
  • Track 11-3Red Blood Cells (RBC)
  • Track 11-4White Blood Cells (WBC)
  • Track 11-5Platelets
  • Track 11-6Erythrocytes & Leukocytes

Blood malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukaemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes. The other types of Blood Malignancies also include sarcoma, lymphodema, Non-Hodgkin lymphoma (NHL) and lymphoma, lymphoid cancer, bone marrow cancer.

  • Track 12-1Leukemia
  • Track 12-2Myeloma
  • Track 12-3Sarcoma
  • Track 12-4Myelodysplastic Syndrome
  • Track 12-5Myeloproliferative Neoplasms
  • Track 12-6Non-Hodgkin Lymphoma (NHL)
  • Track 12-7Bone Marrow Cancer
  • Track 12-8Childhood Haematological Cancers

Blood Disorder is a condition in which there's an issue with red blood cells, white blood cells, or the littler, circulating cells called platelets, which are basic for cluster arrangement. Each of the three cell sorts shape in the bone marrow, which is the delicate tissue inside bones. Blood disorders can also affect the liquid portion of blood, called plasma.

  • Track 13-1Sickle cell Anemia
  • Track 13-2Thrombocytopenia
  • Track 13-3Blood Cancer and Anemia
  • Track 13-4Hemophilia
  • Track 13-5Thrombosis and Haemostasis
  • Track 13-6Blood Transfusion
  • Track 13-7Blood Cancer & Risk Factors
  • Track 13-8Blood disorder diagnosis & treatment

The cause is usually different from other types of cancer. Experts say that Blood Malignancies arise due to different causes, some of them are suspected and some are yet to be. It is nearly impossible to prove what caused a blood cancer in any individual, because most blood cancers have multiple possible causes.

Discussions will be carried out on the suspecting and suspected causes of blood cancer that include: Exposure to radiation and chemicals, Genetic predisposition, drugs, Human T-cell Leukemia Virus (HTLV), Electromagnetic energy, Genetic factors (chromosomal abnormalities, maternal fetal transmission rare).

  • Track 14-1Causes & Symptoms
  • Track 14-2Bone Marrow Transplantation
  • Track 14-3Diagnosis & Treatment
  • Track 14-4Hematological Malignancies: Prognosis

Breast malignancy begins when cells in the bosom start to become wild. These cells for the most part shape a tumor that can frequently be seen on an x-beam or felt as a knot. The tumor is dangerous (disease) if the cells can develop into (attack) encompassing tissues or spread (metastasize) to inaccessible zones of the body. Bosom growth happens totally in ladies, yet men can get breast cancer, as well.

Hazard elements for creating breast tumor incorporate being female, weight, absence of physical work out, drinking liquor, hormone substitution treatment amid menopause, ionizing radiation, early age at first period, having youngsters late or not in the least, more established age, and family history.

  • Track 15-1Types of Breast Cancer
  • Track 15-2Causes & Symptoms
  • Track 15-3Diagnosis & Treatment
  • Track 15-4Women Health
  • Track 15-5Mammogram

A gynecologic oncologist is an obstetrician/gynecologist who works in the analysis and treatment of ladies with tumor of the conceptive organs including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. With a specific end goal to wind up distinctly a gynecologic oncologist in the United States, a doctor should first entire an endorsed, 4-year residency program in obstetrics and gynecology. Taking after this, he/she should finish a 2–4 year clinical partnership in gynecologic oncology.

  • Track 16-1Ovarian Cancer
  • Track 16-2Uterine Cancer
  • Track 16-3Vaginal Cancer
  • Track 16-4Cervical Cancer
  • Track 16-5Vulvar Cancer

Onco-cardiology is a restorative subspecialty Caused with the finding and treatment of heart illness in cancer patients. A portion of the new anticancer medications are so powerful they can hold tumours under wraps, however it's their cardiovascular symptoms that can debilitate to stop life. A passing from treatment related heart disappointment in a patient whose malignancy is going away might be a definitive incongruity—the final knockout originating from blow-back even while the war on tumor is being won.

Prostate cancer is a harm of one of the significant male sex organs. Alongside the gonads and the original vesicles, the prostate secretes the liquid that makes up semen. The prostate is about the measure of a walnut and lies simply behind the urinary bladder. A tumor in the prostate meddles with legitimate control of the bladder and ordinary sexual working. Components that expansion the risk of prostate tumor includes: more seasoned age, a family history of the infection, and race. Around 99% of cases happen in those beyond 50 years old.

  • Track 18-1Classification of prostate cancer
  • Track 18-2Causes of prostate cancer
  • Track 18-3Signs and symptoms
  • Track 18-4Treatments for prostate cancer

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests. These scientific sessions will include the discussion on various topics such as Immunotherapeutic approaches, immune tolerance and deficiencies, Anti-Blood Cancer Factor and immunotherapy.

 
  • Track 19-1Immune Tolerance and Deficiencies
  • Track 19-2Anti-Blood Cancer Factor
  • Track 19-3Immunotherapy
  • Track 19-4Blood Cancer Immunology
  • Track 19-5Immunotherapeutic Approaches

The "Tumor bioinformatics" topical arrangement concentrates on the most recent advancements in the rising field of frameworks clinical prescription in malignancy which coordinates frameworks science, clinical science, omics-based innovation, bioinformatics and computational science to enhance conclusion, treatments and anticipation of disease.

Despite the fact that mutagen and cancer-causing agent are not synonymous terms, the capacity of a substance to actuate changes and its capacity to instigate disease are firmly corresponded. Mutagenesis refers to procedures that outcome in hereditary change, and carcinogenesis the procedures of tumor improvement may come about because of mutagenic occasions.

Cancer epidemiology is concerned with the estimation and study of cancer and its prevalence in a certain area of population, to conclude the possible trends, causes of cancer and develop improved treatments by the use of epidemiological methods. Cancer epidemiology is principally concerned with the study of cancer, its causes, detection, and treatment based on the progression of the disease.           

  • Track 22-1Epidemiology of Blood Cancer

A case report is a detailed report consisting the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. A case report is generally considered a type of evidence of the work carried out and the output attained.

Case studies are extremely useful records of the clinical practices of a profession. They are a record of clinical interactions which help us to frame questions for more rigorously designed clinical studies. Case studies also provide valuable teaching material, demonstrating both classical and unusual presentations which may challenge the practitioner.

  • Track 23-1Diagnostic Case Reports
  • Track 23-2Symptom based Case Reports
  • Track 23-3Therapy based Case Report
  • Track 23-4Medication based Case Report
  • Track 23-5Research based Case Report

An Oncology Nurse gives care to malignancy patients and those at hazard for getting the malady. They screen physical conditions, recommend solution, and oversee chemotherapy and different medicines. Oncology nursing frequently serves as your first line of correspondence, and help to organize the numerous parts of your care all through growth treatment.

  • Track 24-1Evidence-Based Practice
  • Track 24-2Standards Of Oncology Nursing Practice
  • Track 24-3Recent Innovations In Nursing Practice
  • Track 24-4Oncology Nursing And Cancer care
  • Track 24-5Innovations In Patient Care
  • Track 24-6Diagnosis And Treatment Of Acute Illness And Chronic Condition
  • Track 24-7Cancer Pain Management
  • Track 24-8Cancer Awareness and Survival

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

 

  • Track 25-1World Cancer Market